The definition and treatment of critical limb-threatening ischemia (CLTI) have been evolving, recognizing the importance of early recognition and aggressive treatment required for those patients. In this article, the authors discuss the historical definitions of CLTI and provide an overview of how the management of patients with CLTI has developed, including surgical and endovascular interventions.
In this study and review, the authors aim to provide a focused evaluation of the influence of SES on the care, prevalence, and treatment of peripheral arterial disease and critical limb-threatening ischemia.
Experience a live, complimentary event on April 20 with 15+ experts on endovascular technology, innovations, case studies, and more. Save your spot now. You don’t want to miss out on this event!
Dr Pliagas discusses his retrospective study, recently published in JCLI, in which he and his co-investigators sought to demonstrate safety and performance of the Terumo Glidesheath Slender for tibiopedal access. Initially, tibiopedal access was considered a very experimental technique, but over the past few years, Dr Pliagas and his colleagues have learned to routinely gain access to vessels from below, using this technique.
Drs Driver and Neville discuss the crucial component of podiatry in the multidisciplinary treatment of CLTI.
Dr John H Rundback discusses his recent JCLI article, "Patterns of Failure in Deep Venous Arterialization and Implications for Management."
Daniel Clair, MD, Chair of Vascular Surgery from Vanderbilt University Medical Center discusses a number of interesting findings discovered during the BEST CLI trial.
Study co-author George Adams, MD, offers further insight into the topic in the video commentary below.